Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Mar 15, 2025; 17(3): 102728
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.102728
Table 1 Baseline characteristics of study patients stratified by computed tomography-based obstructive degree severity, n (%)
Characteristic
CTOD non-severe (CTOD 1-2)
CTOD severe (CTOD 3)
P value
PNP0.08960.06890.405
P/D4.0807.120< 0.001
Age (> 65 years)71 (50.4)15 (46.9)0.722
Sex (female)58 (41.1)14 (43.8)0.786
BMI (≥ 18.5 kg/m²)108 (83.7)23 (85.2) 0.850
ALB (≥ 35 g/L)72 (51.1)14 (43.8)0.455
CEA (> 5ug/L)71 (51.4)18 (58.1)0.505
Hb (< 9 g/L)20 (14.2)4 (12.5)0.803
ASA 3-442 (29.8)12 (37.5)0.395
Surgical history34 (24.1)11 (34.3)0.232
Comorbidities79 (56.0)18 (56.3)0.982
SEMS44 (31.2)13 (40.6)0.306
Left-sided81 (57.4)21 (65.6)0.396
Surgical method0.647
    Stoma/SEMS16 (11.4)4 (12.5)
    SBTS33 (23.4)10 (31.3)
    Resection92 (65.2)18 (56.3)
Surgical time (minutes)204.4209.070.223
Bleeding (mL)1001000.811
Total number of LN19190.675
Positive LN110.184
Complication62 (44.0)21 (65.6)0.027
SAE20 (14.2)5 (15.6)0.834
Mortality within 30 days1 (0.7)0 (0.0)1.000
Re-bowel obstruction4 (2.8)2 (6.3)0.307
ICU stay13 (9.2)3 (9.4)0.978
Pneumonia21 (14.9)11 (34.4)0.010
Incision infection21 (14.9)3 (9.4)0.415
pT 4 stage51 (36.2)11 (34.4)0.981
pN 1-2 stage81 (57.4)18 (56.3)0.981
pM 1 stage42 (29.8)5 (15.6)0.104
Sepsis5 (3.5)1 (3.1)1.000
Chemotherapy74 (52.5)14 (43.8)0.502
Gas time (day)330.869
Oral intake (day)440.625
Total hospital stay (day)1925.50.004
Post-surgery stay (day)1212.50.021